NW
TMO icon

NewEdge Wealth’s Thermo Fisher Scientific TMO Stock Holding History

NewEdge Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.36M Sell
10,697
-5,139
-32% -$2.47M 0.05% 225
2026
Q1 		$7.78M Sell
15,836
-2,108
-12% -$1.14M 0.09% 157
2025
Q4 		$10.4M Buy
17,944
+7,337
+69% +$4.15M 0.12% 132
2025
Q3 		$6.02M Sell
10,607
-892
-8% -$415K 0.09% 181
2025
Q2 		$5.23M Buy
11,499
+161
+1% +$67.3K 0.08% 191
2025
Q1 		$5.64M Sell
11,338
-2,626
-19% -$1.42M 0.1% 166
2024
Q4 		$7.26M Buy
13,964
+797
+6% +$438K 0.13% 140
2024
Q3 		$8.14M Buy
13,167
+7,429
+129% +$4.4M 0.15% 139
2024
Q2 		$3.17M Sell
5,738
-446
-7% -$256K 0.07% 236
2024
Q1 		$3.53M Buy
6,184
+648
+12% +$364K 0.08% 213
2023
Q4 		$2.94M Sell
5,536
-395
-7% -$191K 0.08% 229
2023
Q3 		$3M Sell
5,931
-1,121
-16% -$597K 0.1% 183
2023
Q2 		$3.68M Buy
7,052
+3,521
+100% +$1.9M 0.12% 152
2023
Q1 		$2.04M Sell
3,531
-246
-7% -$139K 0.08% 220
2022
Q4 		$2.08M Buy
3,777
+952
+34% +$504K 0.09% 205
2022
Q3 		$1.43M Sell
2,825
-549
-16% -$307K 0.07% 235
2022
Q2 		$1.83M Buy
3,374
+1,016
+43% +$559K 0.08% 200
2022
Q1 		$1.39M Buy
2,358
+1,448
+159% +$832K 0.06% 192
2021
Q4 		$607K Buy
910
+216
+31% +$135K 0.03% 272
2021
Q3 		$397K Sell
694
-423
-38% -$232K 0.02% 227
2021
Q2 		$563K Sell
1,117
-17,060
-94% -$8.05M 0.04% 210
2021
Q1 		$8.3M Buy
18,177
+12,937
+247% +$6.17M 0.82% 32
2020
Q4 		$2.44M Buy
+5,240
New +$2.46M 0.75% 34

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NewEdge Wealth's TMO Position: Q2 2026 in Review

NewEdge Wealth reduced its Thermo Fisher Scientific (TMO) stake by 32% in Q2 2026, selling an estimated $2.47M and leaving 10,697 shares worth $5.36M. The position accounts for 0.05% of the portfolio, ranked #225.

NewEdge Wealth first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.4M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • NewEdge Wealth held 10,697 shares of Thermo Fisher Scientific worth $5.36M as of Q2 2026.
  • NewEdge Wealth sold 5,139 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.47M.
  • Thermo Fisher Scientific made up 0.05% of NewEdge Wealth's portfolio in Q2 2026, its #225 holding.
  • NewEdge Wealth first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • NewEdge Wealth's Thermo Fisher Scientific position peaked at $10.4M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.